Human Molecular Genetics, 2001, Vol. 10, No. 17 1729-1740
© 2001 Oxford University Press
Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry
Medical Microbiology and Immunology, Rowe Program in Human Genetics, School of Medicine, 1 Shields Avenue, University of California, Davis, CA 95616, USA and 1Medical Pathology, University of California Davis Medical Center, Sacramento, CA 95817, USA
Rett syndrome (RTT) is an X-linked, dominant neurodevelopmental disorder caused by mutations in MECP2, encoding the methyl-CpG-binding protein 2 (MeCP2). A major paradox in the pathogenesis of RTT is how mutations in ubiquitously transcribed MECP2 result in a phenotype specific to the central nervous system (CNS) during postnatal development. To address this question, we have used a novel approach for quantitating the level and distribution of wild-type and mutant MeCP2 in situ by immunofluorescence and laser scanning cytometry. Surprisingly, cellular heterogeneity in MeCP2 expression level was observed in normal brain with a subpopulation of cells exhibiting high expression (MeCP2hi) and the remainder exhibiting low expression (MeCP2lo). MeCP2 expression was significantly higher in CNS compared with non-CNS tissues of human and mouse by automated quantitation of MeCP2 on multiple tissue arrays. Quantitative localization of MeCP2 expression phenotypes in normal human brain showed a mosaic, but distinct, distribution pattern, with MeCP2hi neurons highest in layer IV of the cerebrum and MeCP2lo neurons highest in the granular layer of the cerebellum. In female RTT brains, MECP2 mutant-expressing cells were identified as cells negative for the MeCP2 C-terminal epitope. MECP2 mutant-expressing cells were randomly localized in Rett cerebrum and cerebellum and showed normal MeCP2 expression with N-terminal-specific anti-MeCP2. These results demonstrate a CNS-specific cellular phenotype of MeCP2 high expression and suggest that MECP2 mutations in RTT are only manifested in MeCP2hi cells. In addition, our results demonstrate the power of laser scanning cytometry in examining complex cellular phenotypes in disease pathogenesis.
+ To whom correspondence should be addressed. Tel: +1 530 754 7598; Fax: +1 530 752 8692; Email: jmlasalle@ucdavis.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Maezawa, S. Swanberg, D. Harvey, J. M. LaSalle, and L.-W. Jin Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions J. Neurosci., April 22, 2009; 29(16): 5051 - 5061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kerr, M. Alvarez-Saavedra, M. A. Saez, A. Saona, and J. I. Young Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice Hum. Mol. Genet., June 15, 2008; 17(12): 1707 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G.M. Jugloff, K. Vandamme, R. Logan, N. P. Visanji, J. M. Brotchie, and J. H. Eubanks Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice Hum. Mol. Genet., May 15, 2008; 17(10): 1386 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nomura, M. Kimura, T. Horii, S. Morita, H. Soejima, S. Kudo, and I. Hatada MeCP2-dependent repression of an imprinted miR-184 released by depolarization Hum. Mol. Genet., April 15, 2008; 17(8): 1192 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Alvarez-Saavedra, M. A. Saez, D. Kang, H. Y. Zoghbi, and J. I. Young Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis Hum. Mol. Genet., October 1, 2007; 16(19): 2315 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Peddada, D. H. Yasui, and J. M. LaSalle Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome Hum. Mol. Genet., June 15, 2006; 15(12): 2003 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Pelka, C. M. Watson, T. Radziewic, M. Hayward, H. Lahooti, J. Christodoulou, and P. P. L. Tam Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice Brain, April 1, 2006; 129(4): 887 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Arocena, C. K. Iwahashi, N. Won, A. Beilina, A. L. Ludwig, F. Tassone, P. H. Schwartz, and P. J. Hagerman Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells Hum. Mol. Genet., December 1, 2005; 14(23): 3661 - 3671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Duncan Armstrong Neuropathology of Rett Syndrome J Child Neurol, September 1, 2005; 20(9): 747 - 753. [Abstract] [PDF]
|
|
|
|
|
|
D. D. Armstrong Neuropathology of Rett Syndrome J Child Neurol, August 1, 2005; 20(8): 747 - 753. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Brero, H. P. Easwaran, D. Nowak, I. Grunewald, T. Cremer, H. Leonhardt, and M. C. Cardoso Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation J. Cell Biol., June 6, 2005; 169(5): 733 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. N. Thatcher, S. Peddada, D. H. Yasui, and J. M. LaSalle Homologous pairing of 15q11-13 imprinted domains in brain is developmentally regulated but deficient in Rett and autism samples Hum. Mol. Genet., March 15, 2005; 14(6): 785 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Samaco, A. Hogart, and J. M. LaSalle Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3 Hum. Mol. Genet., February 15, 2005; 14(4): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R E Amir, P Fang, Z Yu, D G Glaze, A K Percy, H Y Zoghbi, B B Roa, and I B Van den Veyver Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome J. Med. Genet., February 1, 2005; 42(2): e15 - e15. [Full Text] [PDF]
|
|
|
|
|
|
D. Braunschweig, T. Simcox, R. C. Samaco, and J. M. LaSalle X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain Hum. Mol. Genet., June 15, 2004; 13(12): 1275 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Samaco, R. P. Nagarajan, D. Braunschweig, and J. M. LaSalle Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum. Mol. Genet., March 15, 2004; 13(6): 629 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Zoghbi Postnatal Neurodevelopmental Disorders: Meeting at the Synapse? Science, October 31, 2003; 302(5646): 826 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Jarrar, C. G. Danko, S. Reddy, Y.-J. M. Lee, G. Bibat, and W. E. Kaufmann MeCP2 Expression in Human Cerebral Cortex and Lymphoid Cells: Immunochemical Characterization of a Novel Higher-Molecular-Weight Form J Child Neurol, October 1, 2003; 18(10): 675 - 682. [Abstract] [PDF]
|
|
|
|
|
|
D. Duncan Armstrong, K. Deguchi, and B. Antallfy Survey of MeCP2 in the Rett Syndrome and the Non--Rett Syndrome Brain J Child Neurol, October 1, 2003; 18(10): 683 - 687. [Abstract] [PDF]
|
|